Development of an antirheumatic drug
Includes bibliographical references. === The diamino-diamide ligands have been investigated in an attempt to develop an antirheumatic drug. The ligands N,N'-di-(2-dimethylamino)ethyloxamide and N,N'di-(2-diethylamino)ethyloxamide, were synthesised and characterised using the physical techn...
Main Author: | Voyi, Kuku Vinolia Vuyelwa |
---|---|
Other Authors: | Jackson, Graham Ellis |
Format: | Doctoral Thesis |
Language: | English |
Published: |
University of Cape Town
2016
|
Subjects: | |
Online Access: | http://hdl.handle.net/11427/17187 |
Similar Items
-
VZV-specific T-cell levels in patients with rheumatic diseases are reduced and differentially influenced by antirheumatic drugs
by: David Schub, et al.
Published: (2018-11-01) -
Factors associated with initial or subsequent choice of biologic disease-modifying antirheumatic drugs for treatment of rheumatoid arthritis
by: Yinzhu Jin, et al.
Published: (2017-07-01) -
A case of essential thrombocythemia and ankylosing spondylitis treated with a combination of anagrelide, disease-modifying antirheumatic drugs, and etanercept
by: Zeremski Vanja, et al.
Published: (2016-01-01) -
Immunodeficiency and autoimmunity during biological disease-modifying antirheumatic drug therapy
by: Anna Czekalska, et al.
Published: (2019-08-01) -
Recent evidence comparing combination of conventional synthetic disease-modifying antirheumatic drugs with biologic disease-modifying antirheumatic drugs in rheumatoid arthritis
by: Abhishek Zanwar, et al.
Published: (2017-01-01)